SEARCH

SEARCH BY CITATION

References

  • Bacigalupo, A., Tedone, E., Isaza, A., Soracco, M., Van Lint, M.T., Sanna, A., Frassoni, F., Coccini, D., Gualandi, F. & Lamparelli, T. (1995) CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplantation, 16, 155161.
  • Beatty, P.G., Anasetti, C., Hansen, J.A., Longton, G.M., Sanders, J.E., Martin, P.J., Mickeslon, E.M., Choo, S.Y., Petersdorf, E.W. & Pepe, M.S. (1993) Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood, 81, 249253.
  • Beersma, M., Bijlmakers, M. & Ploegh, H. (1993) Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. Journal of Immunology, 15, 44554464.
  • Broers, A.E., Van Der Holt, R., Van Esser, J.W., Gratama, J.W., Henzen-Longmans, S., Kuenen-Boumeester, V., Loweneberg, B. & Cornelissen J.J. (2000) Increased transplant related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood, 95, 22402245.
  • Casper, J., Camitta, B., Truitt, R., Baxter-Lowe, L.A., Bunin, N., Lawton, C., Murray, K., Hunter, J. & Pietryga, A. & Garbrecht (1995) Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood, 85, 23542363.
  • Couriel, D., Canosa, J., Engler, H., Collins, A., Dunbar, C. & Barrett, A.J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplantation, 18, 347353.
  • Cross, N., Feng, L., Chase, A., Bungey, J., Hughes, T.P. & Goldman, J.M. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia after bone marrow transplantation. Blood, 82, 19291936.
  • Dazzi, F., Szydlo, R.M., Craddock, C.F., Cross, N.C., Kaeda, J., Chase, A., Olavarria, E., Van Rhee, F., Kanfer, E., Apperley, J.F. & Goldman, J.M. (2000) A comparison of single dose and escalating dose regimens of donor lymphocyte infusion for patients who relapse after allografting for chronic myeloid leukemia. Blood, 2000, 6771.
  • De La Fuente, J., Pocock, C.F., Szydlo, R.M., Davis, J.G., Craddock, C., Cwynarski, K., Olavarria, E., Rezvani, K., Kanfer, E., Apperley, J.F. & Goldman, J.M. (2000) Impact of marrow cell dose on the outcome of stem cell allografts for the treatment of chronic myeloid leukaemia: improved survival in unrelated donor allografts receiving a high marrow cell dose (>3·65 × 108/Kg). Blood, abstract no. 2379, in press .
  • Drobyski, W., Ash, R., Canosa, J., McAuliffe, T., Horowitz, M., Lawton, C., Keever, C., Baxter-Lowe, L., Camitta, B. & Garbrecht, F. (1994) Effect of T-cell depletion as graft versus-host disease prophylaxis on engraftment, relapse and disease free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood, 83, 19801987.
  • Enright, H., Davies, S., De For, T., Shu, X., Weisdorf, D., Miller, W., Ramsay, N.K., Arthur, D., Verfaillie, C., Miller, J. & McGlave, P. (1996) Relapse after non T cell depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor and chronic graft versus host disease are protective. Blood, 88, 714720.
  • Foot, A., Pamphilon, D., Caul, E., Roome, A.P., Hunt, L.P., Cornish, J.M. & Oakhill, A. (1998) Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants: no evidence of increased incidence in patients receiving unrelated donor grafts. British Journal of Haematology, 102, 671677.DOI: 10.1046/j.1365-2141.1998.00838.x
  • Glucksberg, H., Storb, R., Tefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295304.
  • Goldman, J., Apperley, J., Jones, L., Marcus, R., Goolden, A.W., Batchelor, R., Hale, G., Waldmann, H., Reid, C.D. & Hows, J. (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. New England Journal of Medicine, 314, 202207.
  • Goldman, J., Gale, R., Horowitz, M., Biggs, J.C., Champlin, R.E., Gluckmann, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M. & McGlave, P.B. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associate with T-cell depletion. Annals of Internal Medicine, 108, 806814.
  • Gooley, T., Leisenring, W., Crowley, J. & Store, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695706.DOI: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.3.co;2-f
  • Gratwohl, A., Hermans, J., Goldman, J.M., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H.J., Niederwieser, D., Ruutu, T., Vernant, J.P., De Witte, T. & Apperley, J. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet, 352, 10871089.DOI: 10.1016/s0140-6736(98)03030-x
  • Hansen, J., Gooley, T., Martin, P., Appelbaum, F., Chauncey, T.R., Clift, R.A., Petersdorf, E.W., Radich, J., Sanders, J.E., Storb, R.F., Sullivan, K.M. & Anasetti, C. (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New England Journal of Medicine, 338, 962968.
  • Hertenstein, B., Hampl, W., Bunjes, D., Wieseneth, M., Duncker, C., Koszinwski, U., Heimpel, H., Arnold, R. & Martens, T. (1995) In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course to active cytomegalovirus infection and disease after BMT. Bone Marrow Transplantation, 15, 387393.
  • Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 547581.
  • Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L. & Niederwieser, D. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86, 20412050.
  • Ljungman, P., Aschan, J., Azinge, A., Brabdt, L., Ehrnst, A., Hammarstrom, V., Klaesson, S., Linde, A., Lonnqvist, B. & Ringden, O. (1993) Cytomegalovirus viremia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. British Journal of Haematology, 83, 118124.
  • Mackinnon, S., Hows, J., Goldman, J., Arthur, C.K., Hughes, T., Apperley, J.F., Jones, L., Batchelor, J.R., Brookes, P. & Catovsky, D. (1990) Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors. Experimental Hematology, 18, 421425.
  • Mackinnon, S., Papadopoulos, E., Carabasi, M., Reich, L., Collins, N.H., Boulad, N.F., Castro-Malaspina, H., Childs, B.H., Gillio, A.P. & Kernan, N.A. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia effect from graft-versus-host disease. Blood, 86, 12611268.
  • Marks, D., Cullis, J., Ward, K., Lacey, S., Szydlo, R., Hughes, T.P., Schwarer, A.P., Lutz, E., Barrett, A.J. & Hows, J.M. (1993) Allogeneic bone marrow transplantation for chronic myeloid leukaemia using sibling and volunteer unrelated donors: a comparison of complications in the first two years. Annals of Internal Medicine, 119, 207214.
  • Martin, P., Hansen, J., Torok-Storb, B., Durnam, D., Przepiorka, D., O'quigley, J., Sanders, J., Sullivan, K.M., Witherspoon, R.P. & Deeg, H.J. (1988) Graft failure in patients receiving T cell depleted HLA-identical allogeneic marrow Transplants. Bone Marrow Transplantation, 3, 445456.
  • Mickelson, E., Longton, G., Anasetti, C., Petersdorf, E., Martin, P., Guthrie, L.A. & Hansen, J.A. (1996) Evaluation of the mixed lymphocyte culture assay (MLC) as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens, 47, 2736.
  • Ochs, L., Shu, X.O., Miller, J., Enright, H., Wagner, J., Filipovich, A., Miller, W. & Weisdorf, D. (1995) Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood, 86, 39793986.
  • O'shea, J., Madrigal, A., Davey, N., Brookes, P., Scott, I., Firman, H., Lechler, R., Goldman, J. & Batchelor, R. (1997) Measurement of cytotoxic T lymphocyte precursor frequencies reveals cryptic HLA class I mismatches in the context of unrelated donor. Bone Marrow Transplantation, 64, 13531356.
  • Petersdorf, E., Gooley, T., Anasetti, C., Anasetti, C., Martin, P.J., Smoth, A.G., Mickelson, E.M., Woolfrey, A.E. & Hansen, J.A. (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood, 92, 35153520.
  • Prasad, V., Kernan, N., Heller, G., O'reilly, R.J. & Yang, S.Y. (1999) DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood, 93, 399409.
  • Przepiorka, D., Ippoliti, C., Panina, A., Goodrich, J., Giralt, S., Van Besien, K., Mehra, R., Deisseroth, A.B., Andersson, B. & Luna, M. (1994) Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplantation, 13, 461464.
  • Reusser, P., Riddell, S., Myers, J. & Greenberg, P.D. (1991) Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection. Blood, 78, 13731380.
  • Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., Kodera, Y. & Takaku, F. (1998) Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. New England Journal of Medicine, 339, 11771185.
  • Schattenberg, A., Preifers, F., Mensink, E., Bar, B., Schaap, N., Van Kessel, A., Van Der Maazen, R. & De Witte, T. (1997) Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome positive CML in first chronic phase. Bone Marrow Transplantation, 19, 12051210.
  • Sehn, L., Alyea, E., Weller, E., Canning, C., Lee, S., Ritz, J., Antin, J.H. & Soiffer, R.J. (1999) Comparative outcomes of T-cell-depleted and non-T-cell depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion. Journal of Clinical Oncology, 17, 561570.
  • Sierra, J., Storer, B., Hansen, J., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelabaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, G.E., Storb, R., Sullivan, K.M. & Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA matching and marrow cell dose. Blood, 89, 42264235.
  • Speck, B., Bortin, M., Champlin, R., Goldman, J.M., Herzig, R.H., McGlave, P.B., Mesner, H.A., Weiner, R.S. & Rimm, A.A. (1984) Allogeneic bone marrow transplantation for chronic myeloid leukaemia. Lancet, I, 665667.
  • Spencer, A., Szydlo, R., Brookes, P., Kaminski, E., Rule, S., Van Rhee, F., Ward, K.N., Hael, G., Waldmann, H., Hows, J.M. & Goldman, J.M. (1995a) Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood, 86, 35903597.
  • Spencer, A., Brookes, P., Kaminski, E., Hows, J.M., Szydlo, R.M., Van Rhee, F., Goldman, J.M. & Batchelor, J.R. (1995b) Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Transplantation, 59, 13021308.
  • Small, T., Papadopoulos, E., Boulad, F., Black, P., Castro-Malaspina, H., Childs, B.H., Collins, N., Gillio, A., George, D., Jakubowski, A., Heller, G., Fazzari, M., Jernan, M., MacKinnon, S., Szabolcs, P., Yong, J.W. & O'reilly, R.J. (1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood, 93, 467480.
  • Szydlo, R., Goldman, J., Klein, J.P., Gale, R.P., Ash, R.C., Bach, F.H., Bradley, B.A., Casper, J.T., Flomenberg, N., Gajewski, J.L., Gluckman, E., Henslee-Downey, P.J., Hows, J.M., Jacobsen, N., Kolb, H.J., Lowenberg, B., Masaoka, T., Rowlings, P.A., Sondel, P.M., Van Bekkum, D.W., Van Rood, J.J., Vowels, M.R., Zhang, M.J. & Horowitz, M.M. (1997) Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Journal of Clinical Oncology, 15, 17671777.
  • Tanekaka, K., Gondo, H., Tanimoto, K., Nagafuji, K., Fujisaki, T., Mizuno, S., Miyamoto, T., Okamura, T., Hayashi, S., Eto, T., Osaki, K., Yamasaki, K., Shibuya, T., Harada, N., Teshima, T., Matsuishi, E., Minematsu, T., Minamishima, Y., Harada, M. & Niho, Y. (1997) Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 19, 241248.
  • Thomas, E., Clift, R., Fefer, A., Appelabaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J. & Doney, K. (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medicine, 104, 155163.
  • Ward, K., Roberts, T. & Van Rhee, F. (1994) Ganciclovir and the prevention of CMV disease after allogeneic BMT: the policy at the Hammersmith Hospital. Bone Marrow Transplantation, 13, 230223 .
  • Webster, A., Lee, C., Cook, D.G., Grundy, J.E., Emery, V.C., Kernoff, P.B. & Griffiths, P.D. (1989) Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet, 2, 681688.